
 [
{
"symbol" : "532300",
"exchange" : "BOM",
"id": "680216",
"t" : "532300",
"e" : "BOM",
"name" : "Wockhardt Limited"
, "f_reuters_url" : "http:\u002F\u002Fstocks.us.reuters.com\u002Fstocks\u002Fratios.asp?rpc=66\u0026symbol=",
"f_recent_quarter_date" : "",
"f_annual_date" : "",
"f_ttm_date" : "",
"financials" :
[{
"f_type" : "Income\u0026nbsp\u003BStatement"
,"url" : "http:www.google.comfinance?fstype=ii&q=BOM:532300"
,"f_figures" :
[
]
},
{
"f_type" : "Balance\u0026nbsp\u003BSheet"
,"url" : "http:www.google.comfinance?fstype=bi&q=BOM:532300"
,"f_figures" :
[
]
},
{
"f_type" : "Cash\u0026nbsp\u003BFlow"
,"url" : "http:www.google.comfinance?fstype=ci&q=BOM:532300"
,"f_figures" :
[
]
}],
"kr_recent_quarter_date" : "Q4 (Dec \u002717)",
"kr_annual_date" : "2017",
"kr_ttm_date" : "TTM",
"keyratios" :
[
{
"title" : "Net profit margin",
"recent_quarter" : "-4.23%",
"annual" : "-5.63%",
"ttm" : "-19.07%"
},
{
"title" : "Operating margin",
"recent_quarter" : "0.74%",
"annual" : "-3.06%",
"ttm" : "-18.74%"
},
{
"title" : "EBITD margin",
"recent_quarter" : "",
"annual" : "0.65%",
"ttm" : "-5.34%"
},
{
"title" : "Return on average assets",
"recent_quarter" : "",
"annual" : "-2.65%",
"ttm" : ""
},
{
"title" : "Return on average equity",
"recent_quarter" : "",
"annual" : "-5.50%",
"ttm" : ""
},
{
"title" : "Employees",
"recent_quarter" : "6,768",
"annual" : "-",
"ttm" : "-"
}
]
, "c" : "+2.00",
"l" : "787.00",
"cp" : "0.25",
"ccol" : "chg",
"op" : "791.00",
"hi" : "796.50",
"lo" : "776.35",
"vo" : "102,808.00",
"avvo" : "",
"hi52" : "1,012.00",
"lo52" : "531.50",
"mc" : "86.93B",
"pe" : "",
"fwpe" : "",
"beta" : "",
"eps" : "-56.85",
"dy" : "1.27",
"ldiv" : "10.00",
"shares" : "110.63M",
"instown" : "",
"eo":""
, "related" : [
{
"id" : "680216",
"name" : "Wockhardt Limited",
"t" : "532300",
"e" : "BOM",
"l" : "787.00",
"c" : "+2.00",
"mc" : "86.93B",
"cp" : "0.25",
"ccol" : "chg"
}
,
{
"id" : "7489710",
"name" : "Brooks Laboratories Ltd",
"t" : "BROOKS",
"e" : "NSE",
"l" : "94.00",
"c" : "-0.30",
"mc" : "1.51B",
"cp" : "-0.32",
"ccol" : "chr"
}
,
{
"id" : "6875082",
"name" : "Morepen Laboratories Limited",
"t" : "MOREPENLAB",
"e" : "NSE",
"l" : "36.10",
"c" : "+0.75",
"mc" : "16.26B",
"cp" : "2.12",
"ccol" : "chg"
}
,
{
"id" : "13313409",
"name" : "GlaxoSmithKline Pharmaceuticals Limited",
"t" : "GLAXO",
"e" : "NSE",
"l" : "2,399.00",
"c" : "-5.70",
"mc" : "204.03B",
"cp" : "-0.24",
"ccol" : "chr"
}
,
{
"id" : "5032817",
"name" : "Jubilant Life Sciences Ltd",
"t" : "JUBILANT",
"e" : "NSE",
"l" : "879.45",
"c" : "-4.35",
"mc" : "140.53B",
"cp" : "-0.49",
"ccol" : "chr"
}
,
{
"id" : "3900000",
"name" : "Smruthi Organics Ltd",
"t" : "540686",
"e" : "BOM",
"l" : "111.70",
"c" : "-2.80",
"mc" : "426.18M",
"cp" : "-2.45",
"ccol" : "chr"
}
,
{
"id" : "6286747",
"name" : "Anuh Pharma Ltd",
"t" : "506260",
"e" : "BOM",
"l" : "169.00",
"c" : "-0.05",
"mc" : "4.19B",
"cp" : "-0.03",
"ccol" : "chr"
}
,
{
"id" : "16770484",
"name" : "Suven Life Sciences Ltd.",
"t" : "SUVEN",
"e" : "NSE",
"l" : "191.70",
"c" : "+1.75",
"mc" : "24.42B",
"cp" : "0.92",
"ccol" : "chg"
}
,
{
"id" : "4291267",
"name" : "Lyka Labs Limited",
"t" : "LYKALABS",
"e" : "NSE",
"l" : "58.00",
"c" : "+1.55",
"mc" : "1.63B",
"cp" : "2.75",
"ccol" : "chg"
}
,
{
"id" : "12258597",
"name" : "Cadila Healthcare Ltd",
"t" : "CADILAHC",
"e" : "NSE",
"l" : "408.80",
"c" : "+2.25",
"mc" : "419.59B",
"cp" : "0.55",
"ccol" : "chg"
}
,
{
"id" : "1584468",
"name" : "Wyeth Limited",
"t" : "WYETH",
"e" : "NSE",
"l" : "0.00",
"c" : "",
"mc" : "",
"cp" : "",
"ccol" : ""
}
]
, "summary" : [{
"address": "Wockhardt Towers Bandra Kurla Complex, Bandra (East), MUMBAI, 400051, India",
"phone": "+91-22-26534444",
"fax": "+91-22-26523905",
"url": "http:\u002F\u002Fwww.wockhardt.com\u002F",
"overview" : "Wockhardt Limited is a pharmaceutical and biotechnology company. The Company\u0027s businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Its products include Ace Proxyvon, Bio-Corneum, Aceroc, Alphadopa, Biovac Typhoid, Acetic Acid Otic Solution, Amlodipine Besylate Tablets, Adenosine Injection, Amoxicillin and Clavulanate Potassium for Oral Suspension, Azithromycin Tablets, Aciclovir Powder for Injection, Alendronic Acid, Amitriptyline, Clarithromycin, Entacapone Tablet and Flucloxacillin Injection. It operates a chain of approximately 10 super specialty hospitals, which offer treatment and care facilities in cardiology, neurosurgery, orthopedics, critical care, oncology, nephrology, urology and others. It has over 10 manufacturing plants located in India, the United Kingdom, Ireland and the United States. The Company has approximately three research centers globally."
} ]
, "management" : [
{
"name" : "Habil F. Khorakiwala",
"title" : "Executive Chairman of the Board, Group Chief Executive Officer"
}
,
{
"name" : "Manas Datta",
"title" : "Chief Financial Officer"
}
,
{
"name" : "Murtaza H. Khorakiwala",
"title" : "Managing Director, Executive Director"
}
,
{
"name" : "Huzaifa H. Khorakiwala",
"title" : "Executive Director"
}
,
{
"name" : "Narendra Singh",
"title" : "Company Secretary"
}
,
{
"name" : "Zahabiya Khorakiwala",
"title" : "Additional Non-Executive Director"
}
,
{
"name" : "Baldev Raj Arora",
"age" : "66",
"title" : "Non-Executive Independent Director"
}
,
{
"name" : "Sanjaya Baru",
"title" : "Non-Executive Independent Director"
}
,
{
"name" : "Davinder Singh Brar",
"title" : "Non-Executive Independent Director"
}
,
{
"name" : "Shekhar Datta",
"title" : "Non-Executive Independent Director"
}
]
,"moreresources" : [
]
}]
